Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Cash from Financing Activities (2016 - 2025)

Merit Medical Systems' Cash from Financing Activities history spans 15 years, with the latest figure at $5.1 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 108.14% year-over-year to $5.1 million; the TTM value through Dec 2025 reached $16.0 million, up 126.66%, while the annual FY2025 figure was $16.0 million, 126.66% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was $5.1 million at Merit Medical Systems, up from -$365000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $472.8 million in Q4 2023 and bottomed at -$54.6 million in Q3 2023.
  • The 5-year median for Cash from Financing Activities is -$9.5 million (2022), against an average of $17.8 million.
  • The largest annual shift saw Cash from Financing Activities skyrocketed 8324.21% in 2023 before it plummeted 3522.33% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$32.5 million in 2021, then surged by 82.29% to -$5.7 million in 2022, then surged by 8324.21% to $472.8 million in 2023, then plummeted by 99.49% to $2.4 million in 2024, then surged by 108.14% to $5.1 million in 2025.
  • Per Business Quant, the three most recent readings for MMSI's Cash from Financing Activities are $5.1 million (Q4 2025), -$365000.0 (Q3 2025), and $4.3 million (Q2 2025).